About the Company
QuidelOrtho Corporation is an American manufacturer of diagnostic healthcare products that are sold worldwide. On May 8, 2020 the U.S. Food and Drug Administration (FDA) issued to Quidel the first emergency use authorization (EUA) for a COVID-19 rapid antigen test, a new category of tests for use in the ongoing pandemic. These diagnostic tests quickly detect fragments of proteins found on or within the virus by testing samples collected from the nasal cavity using swabs.
Sector
Industrial Applications and Services
Industry
Laboratory Analytical Instruments
Employees
196
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on RAPID MICRO BIOSYSTEMS, INC.
Rapid Micro Biosystems Enters into Five-Year, $45 Million Term Loan Facility with Trinity Capital Inc.
Strengthens Company’s financial position and reinforces ability to achieve positive cash flow LEXINGTON, Mass., Aug. 12, 2025 ...
Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Q2 2025 Earnings Call Transcript
Q2 2025 Earnings Call Transcript August 12, 2025 Rapid Micro Biosystems, Inc. misses on earnings expectations. Reported EPS ...
Rapid Micro Biosystems Inc (RPID) Q2 2025 Earnings Report Preview: What To Expect
Rapid Micro Biosystems Inc (NASDAQ:RPID) is set to release its Q2 2025 earnings on Aug 12, 2025. The consensus estimate for ...
Rapid Micro Biosystems, Inc. (RPID) Reports Q2 Loss, Misses Revenue Estimates
Rapid Micro Biosystems, Inc. (RPID) came out with a quarterly loss of $0.27 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to a loss of $0.29 per share a year ago.
Rapid Micro Biosystems, Inc. (RPID) Reports Q3 Loss, Tops ... - Nasdaq
Rapid Micro Biosystems, Inc. (RPID) came out with a quarterly loss of $0.26 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.31 per share a year ago. These figures ...
Rapid Micro Biosystems, Inc. (RPID) Q4 2023 Earnings Call Transcript
Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Q4 2023 Earnings Conference Call March 1, 2024 8:30 AM ETCompany ParticipantsMichael Beaulieu - CFA Vice ...
Why Rapid Micro Biosystems Inc (RPID) Is Skyrocketing So Far In 2025
Number of Hedge Fund Holders In Q3 2024: 3 Rapid Micro Biosystems Inc (NASDAQ:RPID) is a life sciences tech company. It has automated solutions for microbial quality control testing.
Rapid Micro Biosystems, Inc.: Rapid Micro Biosystems Enters into Five-Year, $45 Million Term Loan Facility with Trinity Capital Inc.
Strengthens Company's financial position and reinforces ability to achieve positive cash flow LEXINGTON, Mass., Aug.
Rapid Micro Biosystems, Inc. (RPID) Reports Q1 Loss, Tops ... - Nasdaq
Rapid Micro Biosystems, Inc. (RPID) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to loss of $0.31 per share a year ago.
Similar Companies
Loading the latest forecasts...